The effect of infliximab treatment on insulin resistance in patients with rheumatoid arthritis


Moral Oğuz F., OĞUZ A. , Uzunlulu M.

ACTA CLINICA BELGICA, cilt.62, ss.218-222, 2007 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 62 Konu: 4
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1179/acb.2007.035
  • Dergi Adı: ACTA CLINICA BELGICA
  • Sayfa Sayıları: ss.218-222

Özet

Aim: It is well known that increased insulin resistance is associated with the development of cardiovascular disease in patients with rheumatoid arthritis and that tumour necrosis factor- alpha plays an important role in this process. Infliximab is a chimeric monoclonal anti- tumour necrosis factor- alpha antibody.This study investigates the effects of long term infliximab treatment on insulin resistance in patients with rheumatoid arthritis.